In-use contamination of propofol. A clinical study
- 1 March 1997
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 14 (2) , 178-183
- https://doi.org/10.1097/00003643-199703000-00010
Abstract
Reports about post-operative infections associated with the use of propofol prompted us to investigate the in-use contamination of lipid-formulated intravenous (i.v.) anaesthetics used for general anaesthesia or for sedation of intensive care patients in this department. The level and incidence of extrinsic contamination of propofol ('Diprivan') and of another intravenous anaesthetic, etomidate, formulated in lipid solution ('Etomidat-lipuro') was found to be low during two study periods. However, the need to observe strict aseptic precautions in handling these intravenous drugs must be emphasized.Keywords
This publication has 13 references indexed in Scilit:
- Postoperative Infections Traced to Contamination of an Intravenous Anesthetic, PropofolNew England Journal of Medicine, 1995
- Drawing up propofolAnaesthesia, 1994
- Growth of micro‐organisms in solutions of intravenous anaesthetic agentsAnaesthesia, 1993
- PROPOFOL HANDLING TECHNIQUESActa Anaesthesiologica Scandinavica, 1991
- Propofol sedation after open heart surgery A clinical and pharmacokinetic studyAnaesthesia, 1990
- A microbiological study of the contamination of the syringes used in anaesthesia practiceCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1988
- Propofol infusion for sedation in intensive careAnaesthesia, 1987
- Sterility of Anesthetic Multiple-dose Vials after OpeningAnesthesiology, 1985
- Microbial Growth Comparisons of Five Commercial Parenteral Lipid EmulsionsJournal of Parenteral and Enteral Nutrition, 1984
- In-Use Contamination of Intravenous Infusion FluidApplied Microbiology, 1974